THE DEAL, AT A GLANCE
From the announcementParis-based WhiteLab Genomics
01Who is involvedBacked by Omnes Capital, one of the leading French venture capital firms, Debiopharm, its foundingFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedParis-based WhiteLab Genomics raised announced 2026-10-06From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersWhiteLab Genomics' €23.2 million financing supports a Paris-based company applying AI to genomic medicine development, with potential strategic relevance if its…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Paris-based WhiteLab Genomics · Financing Record
Explore source-linked visual explanations for Paris-based WhiteLab Genomics. Unsupported claims are withheld while source review continues.
Record 13479 · Recorded date: 2026-10-06
Explore company records →